iShares U.S. Pharmaceuticals ETF Rating $100.96 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.72Holdings in IHE have an aggregate rating of Moderate Buy based on 325 analyst ratings issued in the past year covering 25 companies (91.6% of the portfolio).IHE Aggregate Price Target$100.96High Prediction$100.96Average Prediction$100.96Low Prediction$100.96Holdings in IHE have an aggregate price target of $100.96 and a range of $100.96 to $100.96 covering 25 companies (91.6% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IHE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings21.90%JNJJohnson & Johnson$262.52-0.2%4.2635 of 5 stars2.74$256.70 -2.2%27Trending NewsGap Down21.90%LLYEli Lilly and Company$1,208.37-0.5%4.2852 of 5 stars2.87$1,235.07 2.2%30Trending NewsAnalyst UpgradeAnalyst Revision4.44%RPRXRoyalty Pharma$57.774.2987 of 5 stars3.00$53.71 -7.0%7News CoverageInsider TradeGap Down4.44%BMYBristol Myers Squibb$58.05-0.1%4.5984 of 5 stars2.37$61.31 5.6%19Options VolumeAnalyst RevisionGap Down4.43%PFEPfizer$24.29-0.1%4.5408 of 5 stars2.25$28.82 18.7%20Analyst DowngradeAnalyst Revision4.38%MRKMerck & Co., Inc.$129.34-0.2%4.474 of 5 stars2.70$131.83 1.9%20Positive NewsAnalyst ForecastAnalyst RevisionGap Down4.38%VTRSViatris$16.702.7908 of 5 stars2.57$17.50 4.8%7Gap Down4.22%ZTSZoetis$74.74-0.1%4.9439 of 5 stars2.38$126.92 69.8%16Trending NewsAnalyst ForecastGap Down3.47%JAZZJazz Pharmaceuticals$243.473.4208 of 5 stars2.84$246.06 1.1%19Positive News2.92%ELANElanco Animal Health$24.94-0.2%3.6487 of 5 stars2.77$28.55 14.5%13Positive News2.62%AXSMAxsome Therapeutics$244.312.227 of 5 stars2.95$258.95 6.0%21Insider Trade1.86%CORTCorcept Therapeutics$90.212.9125 of 5 stars2.75$88.83 -1.5%8News CoveragePositive News1.30%LQDALiquidia$78.932.9224 of 5 stars2.82$68.88 -12.7%111.29%LGNDLigand Pharmaceuticals$319.552.1979 of 5 stars2.88$257.71 -19.4%81.14%INDVIndivior$39.802.0528 of 5 stars2.75$40.29 1.2%8Negative News0.98%DFTXDefinium Therapeutics$44.192.1093 of 5 stars3.00$46.92 6.2%17Analyst Forecast0.91%CRNXCrinetics Pharmaceuticals$42.233.606 of 5 stars2.91$73.78 74.7%11Positive NewsAnalyst ForecastGap Down0.86%OGNOrganon & Co.$13.57+0.1%2.0854 of 5 stars1.71$11.40 -16.0%70.68%AMRXAmneal Pharmaceuticals$17.152.0412 of 5 stars2.71$15.80 -7.9%70.67%EWTXEdgewise Therapeutics$39.563.353 of 5 stars2.78$47.30 19.6%9Positive NewsInsider Trade0.63%SUPNSupernus Pharmaceuticals$48.052.7304 of 5 stars2.43$62.17 29.4%7News CoverageAnalyst Upgrade0.62%TARSTarsus Pharmaceuticals$65.442.9203 of 5 stars2.78$90.67 38.5%9News CoverageGap DownHigh Trading Volume0.54%NKTRNektar Therapeutics$71.042.9077 of 5 stars2.73$149.63 110.6%11News CoverageInsider TradeGap Down0.53%PBHPrestige Consumer Healthcare$49.38-0.1%4.1087 of 5 stars2.00$70.75 43.3%6News CoveragePositive News0.51%ELVNEnliven Therapeutics$49.823.4153 of 5 stars2.86$67.83 36.2%7Analyst Forecast This page (NYSEARCA:IHE) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
